Navigation Links
Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com
Date:4/21/2009

goBalto establishes new online platform to help pharmaceutical companies find, evaluate and manage drug partners from around the world, reducing inefficiencies in the drug development lifecycle

SAN FRANCISCO, April 21 /PRNewswire/ -- goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today its new platform and website, goBalto.com. goBalto transforms the way drug-development partners are matched. The web-based platform enables members to quickly and efficiently find partners, share knowledge, and discover opportunities.

"U.S. and EU pharmaceutical companies are under pressure to reduce costs and boost efficiencies in the drug development process," said Jae Chung, founder & CEO, goBalto. "As a result, companies are increasingly looking towards outsourcing to help reduce costs. But it's challenging for companies to identify and evaluate drug service providers. goBalto is addressing this by creating an online resource where users can quickly find and evaluate drug service providers, resulting in improved transparency and better decision making."

goBalto incorporates the following key features for its members:

  • Search and browser tools to screen from more than 7,000 potential service providers (investigator sites, CMOs, CROs, and consultants) to help customers find the right partner
  • Lists of potential service providers based on technical capabilities, regulatory compliance, facilities, equipment, and more
  • Capability to rate companies and post comments on vendors
  • Functionality to post about projects and jobs specific to the pharmaceutical industry
  • Ability to make and share collections of vendors for each project
  • Easy to read vendor summary profiles, incorporating videos, images and the latest in Web 2.0 technologies

"In today's highly competitive marketplace, it's critical to be able to find quality partners that can reduce your costs of drug development and time-to-market," said Dr. Cary Queen, Co-Founder of Protein Design Labs. "The goBalto platform provides members with the transparency and ability to quickly identify and evaluate new partners via a rating system that includes rich vendor profiles."

"goBalto provides a great platform for showcasing our drug development and manufacturing capabilities to biotech and pharmaceutical companies around the globe," said Kiran-Mazumdar Shaw, Chairman and Managing Director of Biocon Limited. "The goBalto partnering website provides us with a highly cost-effective channel to reach our target customers compared to traditional options such as industry conferences and advertising."

According to market research company Kalorama, the market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase over the previous year. "The sheer numbers of biologics in the pipeline are driving drug makers to outsource specialized production rather than build new plants," according to Kalorama.

"Most existing sites are "one-way" distributors of content from the publisher to the user," said Mr. Chung. "But users today are seeking a more collaborative platform. We're not only improving transparency, but incorporating the latest in Web social media tools to enable users to share their collective experiences on topics ranging from vendors to regions in which to conduct trials."

About Jae Chung, Founder and CEO

Jae Chung founded goBalto in October 2008. Prior to goBalto, he co-founded Celltrion, a contract biopharmaceutical group in Asia. As Celltrion's vice president of business development, he secured deals with Bristol-Myers Squibb and CSL, and has been credited with landing the largest biomanufacturing supply agreement in Asia to date. Before starting Celltrion in 2002, he was the co-founder of the venture capital firm, J. Stephen & Company Ventures, and a strategy consultant at McKinsey and Company.

About goBalto

goBalto is a dedicated online drug development partnering site for the pharmaceutical and drug manufacturing industry. Users can identify, evaluate, and manage drug-development partners from around the world. Incorporating the latest in Web 2.0 technologies, goBalto's platform enables users to distinguish their offerings by adding logos, images, videos, customer testimonials and post referrals from members. More than 7,000 service providers are currently listed.

Related Link:

goBalto - http://www.gobalto.com/

    Press contacts:
    Jamie O'Donnell
    SEO-PR
    Jamie.odonnell@seo-pr.com
    Phone 415 606 5914

    press@gobalto.com
    Phone 415 671 4372

    For marketing opportunities, contact:
    Erik Sam
    goBalto, Director of Business Development
    esam@gobalto.com
    Phone 415 671 4372


'/>"/>
SOURCE goBalto
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. INDUS Corporation Awarded Army Office of the Surgeon General Contract
2. HMS Awarded Medicaid Provider Audit Contract in Virginia
3. HBA Global Expo Platforms Private Label/Contract Manufacturing
4. California Certifying Board for Medical Assistants Signs Exclusive Contract with Pearson VUE
5. TeamHealth Announces Nine New Contracts in First Quarter 2009
6. Sinobiopharma, Inc. Signs Sales Contract for Flagship Project
7. 57 (More) Reasons to Buy a Contract From College Illinois!(SM)
8. IntelliSoft Group Contracts with New England Hospitals: Berkshire Health Systems and Porter Medical Center
9. TRICOR Systems Inc. Receives ISO 13485 Certification; Contract Manufacturer Achieves Another Significant Milestone in 32 Year History
10. General Services Administration Awards Information Technology Schedule Contract to TeamStaffs Government Staffing Subsidiary
11. HMS Awarded Medicaid Audit Contract in South Carolina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of the most ... touted to be the next revolution in our fight against this complex disease. One ... of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over ... recently, the only option for on-premises installation of its Help System for SharePoint was ... install the system into the entire tenant. , The company recently released a ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
(Date:3/29/2017)... 2017 Neurim Pharmaceuticals ("Neurim") and ... exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... sleep disorders in children with Autism Spectrum Disorders (ASD) and neurogenetic ... for children. The collaboration with Exeltis will help increase ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... to their offering. ... The global patient safety and risk management software market is ... Patient safety has become a priority for almost all ... in the last decade and is currently on the verge of ...
Breaking Medicine Technology: